Keri Kalmbach

Keri Kalmbach

Auto-generated profile, based on publicly available information

Keri Kalmbach

Obstetrics and Gynecology Department of New York University School of Medicine, New York, NY, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
KKKeri Kalmbach
Keri Kalmbach
LRLeRoy G. Robinson
LeRoy G. Robinson
FWFang Wang
Fang Wang
LLLin Liu
Lin Liu
DKDavid Keefe
David Keefe
Telomeres protect and cap linear chromosome ends, yet these genomic buffers erode over an organism’s lifespan. Short telomeres have been associated with many age-related conditions in humans, and genetic mutations resulting in short telomeres in humans manifest as syndromes of precocious aging. In women, telomere length limits a fertilized egg’s capacity to develop into a healthy embryo. Thus, telomere length must be reset with each subsequent generation. Although telomerase is purportedly responsible for restoring telomere DNA, recent studies have elucidated the role of alternative telomeres lengthening mechanisms in the reprogramming of early embryos and stem cells, which we review here.

30 December 2014 in Reproductive Sciences
Verified
Journal Article
Closed access
RDRoberta C. Dracxler
Roberta C. Dracxler
COC. Oh
C. Oh
KKK. Kalmbach
K. Kalmbach
FWF. Wang
F. Wang
LLL. Liu
L. Liu
MAMauricio Abrao
Mauricio Abrao

1 April 2009 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MKMichael J. Kane
Michael J. Kane
KKKeri H Kalmbach
Keri H Kalmbach
CBCarrie L Butler
Carrie L Butler
JDJohn S Dennis
John S Dennis
BCBruce A. Citron
Bruce A. Citron
The mechanisms underlying neuron loss in central nervous system disorders are incompletely understood. We have previously identified dysregulation in several pathways important to neuronal health. In this study, we focus on identifying regulatory factors that could be used to protect and preserve neuronal function following traumatic brain injury (TBI). Elucidation of factors involved in neuronal death will provide targets to achieve therapeutic benefits during a narrow window of opportunity after TBI. Using an in vitro cell injury model, we identified several transcription factors that are upregulated that can result in a proapoptotic gene expression profile, including E26 avian leukemia oncogene 1 (ETS1), interferon regulatory factors (IRF3 and 6), MAD homolog 3 (Smad3), and Wilms tumor homolog (WT1). The expression levels of these factors were elevated about 1.7 fold and 3.5 fold in the case of ETS1. Our data indicate that inflammatory responsive transcription factors, implicated in apoptosis in other tissues, are also important in cell loss in the brain. The identification of these and other factors that regulate neuronal survival following TBI may represent an attractive target for pharmacological intervention. This study was supported by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs, the Bay Pines Foundation, and the Alzheimer's Association.